Advertisement
Screener

NEPHROS, INC. (NEPH) Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate

2.8 / 5 stars · 68/120 Roast Me

NEPHROS, INC. Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate

NEPHROS, INC. (NEPH) reported Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate of 92.10% for the 3-month period ending 2019-03-31, per its 10-Q filed 2019-05-08.

Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate · last filed 2019-05-08

  • NEPHROS, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate for the quarter ending 2019-03-31 was 92.10%.
  • NEPHROS, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate for the quarter ending 2017-03-31 was 110.90%.
  • NEPHROS, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate for fiscal 2018 was 92.42%, a 11.61% decline from fiscal 2017.
  • NEPHROS, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate for fiscal 2017 was 104.56%, a 8.78% decline from fiscal 2016.
  • NEPHROS, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate for fiscal 2016 was 114.63%, a 5.96% decline from fiscal 2015.
  • NEPHROS, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate for fiscal 2015 was 121.90%, a 6.09% decline from fiscal 2014.
Period endShare-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate 3 monthShare-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate 6 monthShare-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate 9 monthShare-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate 12 month
2019-03-3192.10%
10-Q · filed 2019-05-08
2018-12-3192.42%
10-K · filed 2019-03-12
2017-12-31104.56%
10-K · filed 2019-03-12
2017-09-30107.70%
10-Q · filed 2017-11-09
2017-06-30108.00%
10-Q · filed 2017-08-08
2017-03-31110.90%
10-Q · filed 2017-05-09
2016-12-31114.63%
10-K · filed 2018-02-26
2015-12-31121.90%
10-K · filed 2017-03-20
2015-09-30122.80%
10-Q · filed 2015-11-10
2015-06-30122.90%
10-Q · filed 2015-08-10
2014-12-31129.80%
10-K · filed 2016-03-30
2013-12-31129.80%
10-K · filed 2015-04-15

Similar stocks

Stock NameCountryMarket CapPE Ratio
Sensus Healthcare, Inc. (SRTS)United States$0.048B-3.24
SANUWAVE Health, Inc. (SNWV)United States$0.041B5.47
Spectral AI, Inc. (MDAI)United States$0.052B
Xtant Medical Holdings, Inc. (XTNT)United States$0.053B
TELA Bio, Inc. (TELA)United States$0.057B-0.82
InspireMD, Inc. (NSPR)$0.033B
PAVmed Inc. (PAVM)United States$0.031B-3.00
Glucotrack, Inc. (GCTK)United States$0.027B
ACCURAY INC (ARAY)United States$0.027B-0.63
DarioHealth Corp. (DRIO)$0.066B-1.39